New estimates of the costs of adverse events in patients with cancer

The cost of adverse events (AEs) is a critical component of healthcare economic models for cancer treatment; however, few comprehensive estimates of these costs exist. Previous studies focused on costs related to specific AEs, cancer types, or treatment regimens. This study assesses the incremental...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	PloS one Ročník 20; číslo 9; s. e0332703
Hlavní autoři:	Patel, Achal, Schuldt, Robert, Sussell, Jesse
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Public Library of Science 29.09.2025 Public Library of Science (PLoS)
Témata:	Adult Adverse and side effects Adverse events Aged Allergic reactions Allergies Availability Cancer Cancer therapies Care and treatment Chronic lymphocytic leukemia Cost assessments Costs Critical components Data acquisition Drug-Related Side Effects and Adverse Reactions - economics Drugs Economic models Economics Estimates Female Forecasts and trends Health Care Costs Health care expenditures Health care policy Health problems Health services Hodgkin's lymphoma Humans Leukemia Lymphatic leukemia Lymphoma Male Medical diagnosis Medical economics Medicare Melanoma Middle Aged Multiple myeloma Nausea Neoplasms - drug therapy Neoplasms - economics Oncology Patients Photosensitivity Regulatory approval Tumors United States United States Italy
ISSN:	1932-6203, 1932-6203
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!